GLPwatch
Trulicity vs Victoza
Drug comparison
Last updated 2026-05-28 15:46 UTCTrulicity (dulaglutide by Eli Lilly) and Victoza (liraglutide by Novo Nordisk) are both injectable medications for type 2 diabetes and cardiovascular risk reduction. Both are given as once-weekly shots under the skin, but Trulicity is a single-dose pen while Victoza is a multi-dose pen.
AI summary of the sources below.
| Trulicity | Victoza | |
|---|---|---|
| Active ingredient | dulaglutide | liraglutide |
| Manufacturer | eli-lilly | novo-nordisk |
| Route | subcutaneous injection | subcutaneous injection |
| FDA-approved for | type 2 diabetes, cardiovascular risk reduction | type 2 diabetes, cardiovascular risk reduction |
| Label updated | 2023-08-05 | 2023-02-06 |